MRC Molecular & Cellular Medicine Board (MCMB) Research Grants 2021

Open date: 9 Mar 2021

Deadline for applications: 5 May 2021 16:00 (UK+1)

MRC research grants are suitable for focused research projects that may be short- or long-term in nature. In addition, they can be used to support method development or development and continuation of research facilities and may involve more than one research group or institution. A research grant can be awarded for any period of up to five years, but those of two years or less are for proof of principle or pilot work only. Research grants do not cover programmatic approaches or research involving randomised trials of clinical treatments.The budget for research grant awards will not typically exceed £1 million.

The Molecular and Cellular Medicine Board is responsible for MRC’s investments seeking to understand the molecular and cellular mechanisms that underpin complex biological function in human health and disease, and supporting the early translation of knowledge towards new diagnosis and treatment, and changes to policy and practice. The Board seeks to extend our understanding of structure-function insights of molecules and complexes, how the cellular environment functions during development and mature states, and how biological systems respond to external insults (e.g. drugs and toxins) and disease states. The Board leads MRC’s investments in cancer, from fundamental discovery science to epidemiology, experimental medicine and early translation.

Who can apply?

Any UK-based researcher who can demonstrate that they will direct the proposed research and be actively engaged in carrying it through. The minimum academic qualification required is a graduate degree, although usually a PhD is required. Less experienced researchers should apply in collaboration with a more senior colleague. Applications can include an industry partner(s).

For the full call text please visit the MRC grant call webpage.